| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Apr 10, 2023 | Option Exercise | $3.57 | 200 | 714 | 100 | Apr 12, 2023, 05:03 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Apr 11, 2023 | Option Exercise | $3.57 | 16,902 | 60,357 | 8,451 | Apr 12, 2023, 05:03 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Apr 12, 2023 | Option Exercise | $3.57 | 11,166 | 39,874 | 5,583 | Apr 12, 2023, 05:03 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Apr 05, 2023 | Option Exercise | $3.57 | 13,934 | 49,758 | 6,967 | Apr 07, 2023, 04:43 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Apr 06, 2023 | Option Exercise | $3.59 | 54,386 | 195,028 | 27,193 | Apr 07, 2023, 04:43 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Mar 31, 2023 | Option Exercise | $3.57 | 5,214 | 18,619 | 2,607 | Apr 04, 2023, 07:00 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Apr 03, 2023 | Option Exercise | $3.58 | 200 | 715 | 100 | Apr 04, 2023, 07:00 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Apr 04, 2023 | Option Exercise | $3.59 | 14,532 | 52,112 | 7,266 | Apr 04, 2023, 07:00 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Feb 01, 2023 | Sale | $3.83 | 35,116 | 134,478 | 17,558 | Feb 03, 2023, 04:32 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Feb 02, 2023 | Sale | $3.96 | 23,150 | 91,581 | 11,575 | Feb 03, 2023, 04:32 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Jan 03, 2023 | Option Exercise | $3.06 | 21,026 | 64,266 | 10,513 | Jan 05, 2023, 05:31 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Jan 04, 2023 | Option Exercise | $3.03 | 18,306 | 55,403 | 9,153 | Jan 05, 2023, 05:31 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Jan 05, 2023 | Option Exercise | $3.01 | 18,934 | 57,020 | 9,467 | Jan 05, 2023, 05:31 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Dec 05, 2022 | Option Exercise | $3.34 | 28,266 | 94,267 | 14,133 | Dec 06, 2022, 05:31 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Dec 02, 2022 | Option Exercise | $3.55 | 30,000 | 106,500 | 15,000 | Dec 06, 2022, 05:31 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Nov 01, 2022 | Option Exercise | $3.89 | 46,858 | 182,278 | 23,429 | Nov 03, 2022, 04:53 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Nov 02, 2022 | Option Exercise | $3.87 | 11,408 | 44,168 | 5,704 | Nov 03, 2022, 04:53 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Oct 10, 2022 | Option Exercise | $3.64 | 49,702 | 181,164 | 24,851 | Oct 12, 2022, 04:09 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales & Marketing | Oct 11, 2022 | Option Exercise | $3.68 | 8,564 | 31,473 | 4,282 | Oct 12, 2022, 04:09 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales | Nov 12, 2021 | Option Exercise | $6.75 | 85,180 | 574,965 | 42,590 | Nov 16, 2021, 07:10 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales | Nov 15, 2021 | Option Exercise | $6.50 | 102,704 | 667,576 | 51,352 | Nov 16, 2021, 07:10 PM | |
| MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Global Sales | Nov 16, 2021 | Option Exercise | $6.46 | 62,326 | 402,626 | 31,163 | Nov 16, 2021, 07:10 PM |
Menu